The Structure and Activity of a Monomeric Interferon-γ:α-Chain Receptor Signaling Complex  by Randal, Michael & Kossiakoff, Anthony A.
Structure, Vol. 9, 155–163, February, 2001, ª 2001 Elsevier Science Ltd. All rights reserved. PII S0969-2126(01)00567-6
The Structure and Activity of a Monomeric
Interferon-g:a-Chain Receptor Signaling Complex
Introduction
Hormones belonging to the cytokine superfamily induce
Michael Randal*k and Anthony A. Kossiakoff†‡§#
*Graduate Group in Biophysics
University of California
San Francisco, California 94000 a wide variety of crucial biological activities through
a common mechanism of hormone-induced receptor†Genentech Inc.
1 DNA Way aggregation [1]. Within this superfamily, the interferons
act as potent agents that provide an important hostSouth San Francisco, California 94080
‡Institute for Biophysical Dynamics defense response to viral and bacterial infection [2]. The
interferons are subdivided into two distinct types basedUniversity of Chicago
Chicago, Illinois 60637 on their biological response, structure, origin, and struc-
tural organization of their signaling complexes [3]. The
Type 1 interferons, IFN-a and IFN-b, are four-helix bun-
dle proteins that display cross-reactivity among shared
Summary receptors. IFN-g, a Type 2 interferon, has no structural
similarity to either of the Type 1 interferons and is char-
Background: Interferon-g (IFN-g) is a homodimeric cy- acterized by a high degree of receptor specificity. IFN-g
tokine that exerts its various activities by inducing the is a symmetric homodimer with a tertiary fold built
aggregation of two different receptors. The a chain re- around an unusual pattern of interdigitating a helices,
ceptor (IFN-gRa) is a high affinity receptor that binds to similar to that seen in IL-10 [4, 5].
IFN-g in a symmetric bivalent manner to form a stable, IFN-g mediates its biological activities through bind-
intermediate 1:2 complex. This intermediate forms a ing to the extracellular domains of two different Class
binding template for the subsequent binding of two cop- 2 single-pass transmembrane receptors [6]: the high
ies of the second receptor, b chain receptor (IFN-gRb), affinity a chain receptor (IFN-gRa) and a low affinity b
producing the active 1:2:2 signaling complex. chain receptor, (IFN-gRb) [7]. The bivalent nature of the
IFN-g homodimer provides for the organization of the
active symmetric signaling complex composed of oneResults: A single chain monovalent variant of IFN-g
hormone homodimer and two copies of both IFN-gRa(scIFN-g) was constructed and complexed to one copy
and IFN-gRb in a 1:2:2 stoichiometry [8]. The markedof the extracellular domain (ECD) of IFN-gRa. The struc-
difference in the binding affinities of the two receptorsture of this 1:1 complex was determined and the hor-
results in a sequential set of binding events. The firstmone-receptor interface shown to be characterized by a
step involves the binding of IFN-g to IFN-gRa formingnumber of hydrophilic interactions mediated by several
a 1:2 complex, an intermediate confirmed by the 2.9 A˚highly ordered water networks. The scIFN-g interface
structures of Walter et al. [9] and Thiel et al. [10]. It hadconsists of segments from each of the monomer chains
been supposed that the IFN-gRb can only bind onceof the homodimer. The principal hydrophobic contact
this intermediate is formed. This suggests that IFN-gRbof the receptor involves a tripeptide segment of the
uses binding elements on both IFN-g and IFN-gRa. Al-receptor having an unusual and high energy conforma-
though the biologically relevant signaling complex hastion. Despite containing only one binding site for IFN-
a 1:2:2 stoichiometry, it is possible that all the required
gRa, the monovalent scIFN-g molecule has significant
signaling components are present in a hormone com-activity in antiviral biological assays.
plex that contains only one copy of IFN-gRa and
IFN-gRb.
We have constructed a monovalent form of IFN-g thatConclusions: ScIFN-g binds the ECD of IFN-gRa
binds only a single copy of the IFN-gRa molecule (andthrough a highly hydrated interface with an important
by inference, one copy of IFN-gRb) [11]. This variantset of hormone-receptor contacts mediated through
IFN-g molecule was made by linking the C-terminal endstructured waters. Although the interface is highly hy-
of one chain of the homodimer to the N terminus of thedrated, it supports tight binding and has a considerable
second chain. Randal et al. showed that this single chaindegree of specificity. The biological activity of scIFN-g
construct (scIFN-g) allows for the selective introductionconfirms that the scIFN-g:IFN-gRa complex represents
of mutations that eliminate one of the hormone-receptora productive intermediate and that it can effectively re-
binding sites without affecting the other [11]. We showcruit the other required component, IFN-gRb, to signal
that the monovalent scIFN-g:IFN-gRa complex reportedbased on the 1:1:1 complex.
here is a competent intermediate that can bind the IFN-
gRb to produce effective signaling. This supports other
§ To whom correspondence should be addressed (e-mail: koss@ recent studies that have shown that the 1:1:1 stoichiom-
cummings.uchicago.edu). etry is a viable signaling complex [12, 13].k Present address: Sunesis Pharmaceuticals Inc., 3696 Haven Ave-
nue Suite C, Redwood City, California 94062.
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ences Building, Chicago, Illinois 60637. hormone-receptor complex; interferon-g
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Figure 1. Ribbon Diagram of the scIFN-g: IFN-gRa 1:1 Complex
The two different momomer chains of the homodimeric IFN-g are
designated by red and yellow, illustrating the pattern of interdigitat-
ing helices that constitutes the two domain structure of the hormone.
Monomer 2 helices are marked by (’). The linker position connecting
the C and N termini of each of the chains (F!A’) is marked. The
last C-terminal 6 residues of helix F’ are disordered in the structure
as is the BC loop of the C-terminal domain of IFN-gRa, which is
proposed to be a potential binding partner with these residues.
Figure generated using MIDASPLUS [51].
Crystals of the 1:1 scIFN-g:IFN-gRa ECD complex dif-
Figure 2. Decrease in Solvent Accessibility Upon Complex For-fract to beyond 2.0 A˚ [11]. The higher resolution structure
mationcontains some notable differences compared to the pre-
Surface area buried for scIFN-g (top) and IFN-gRa (bottom) calcu-viously reported 2.9 A˚ structure of the 1:2 IFN-g:IFNgRa
lated using AREAIMOL [47]. The two repeats of IFN-g are distin-
ECD complex [9]. In particular, it shows that ordered guished by black bars (monomer 1) and gray bars (monomer 2).
water networks play a pertinent role in the organization
of the hormone-receptor interface. Surprisingly, a muta-
shown to increase receptor affinity and antiviral activitytion (His111Asp) that significantly affects hormone-
[14].receptor binding does not act through a direct protein–
There is little change in the structure of IFN-g uponprotein interaction, but apparently through disruption of
receptor binding. Comparison of scIFN-g in the 1:1 re-the protein–water contacts (see below). Additionally, the
ceptor complex reported here and the structures of bo-structure identifies unusual stereochemistries that pre-
vine IFN-g [15] (2.0 A˚) and a similar human single-chainsumably occur to maximize van der Waals contact be-
construct [13] (2.9 A˚) gives rmsd’s of 1.6 A˚ and 1.0 A˚,tween a section of the interface.
respectively, for all common Cas (1–120, 39–169, 249–1219:
primed numbers signifying residues contained in the
second monomer chain). Removal of the termini (resi-Results
dues 1–2, 1219) and the BC and CD loops (residues
37–41, 60–63, 379–419, 619–649) from this comparisonOverall Structure of the 1:1 Complex
Figure 1 shows a ribbon representation of the scIFN- lowers the rmsd’s to 1.0 A˚ and 0.9 A˚.
The extracellular region of the IFN-gRa consists ofg:IFN-gRa complex. Native IFN-g is a symmetric two-
domain homodimer. The wild-type human IFN-g mono- two fibronectin type III (FNIII) repeats connected by a
short linker. In IFN-gRa, each repeat contains about 110mer contains 143 residues that when folded consists of
six a helices connected by short loops. In the homodi- amino acids that form a b sandwich consisting of a
three-stranded (A, B, E) and a four-stranded (G, F, C,mer, these helices are arranged in an interdigitating
fashion; the first four helices of one monomer (helices C’) b-sheet (Figure 1). The N- and C-terminal domains
of the receptor are related by an z1208 angle, similarA–D) and the last two helices of the second monomer
(helices E’ and F’) form a structural domain (Figure 1). to that seen for tissue factor [16], another Type 2 recep-
tor. In contrast, the interdomain angles for the TypeIn the scIFN-g molecule, residue 119 of one monomer
has been connected to residue 4 of the other monomer 1 receptors are more acute (human growth hormone
receptor [17], 908; human prolactin receptor [18], 1038;by an 8 residue linker [11]. Ten residues have also been
truncated from the C terminus, a deletion previously rat prolactin receptor, 1088 and 1148 [19]; erythropoietin
A 1:1 IFN-g:IFN-gRa Complex at 2.0 A˚
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Figure 4. Simulated Annealing Electron Density Map
Stereo view of a simulated annealing electron density map (2Fo-Fc,
1s) in which the displayed residues (H205, V206, and W207) were
left out of the phasing model (MOLSCRIPT [53]).
strand F, as well as the BC, C’E, and FG loops of the
second FNIII domain (D2).
Figure 3 shows a surface representation of the recep-
tor. Superimposed on this surface is the set of the hor-
mone residues that lose exposed surface area upon
complex formation. The hydrophobic receptor residues
Tyr49, Trp82, Val206, and Trp207 account for z40%
of the buried surface of the receptor. In contrast, four
hydrophilic residues account for approximately one-
third of the hormone buried surface: Ser20, Ala23 (main
chain), His111’, and Gln115’. A dominant feature of this
interaction is the protruding surface created by IFN-gRa
residues Tyr49, Trp82, and Glu101. This “knob” sits in
a “hole” on the surface of the IFN-g molecule bounded
by residues His111’ and Glu112’ on one side and by the
loop connecting helices A and B on the other.
Another interacting surface is created by the receptor
Figure 3. View of the IFN-g:IFN-gRa Interface tripeptide, His205/Val206/Trp207, with each of the three
Ribbon representation of the IFN-g receptor binding epitope (yellow) side chains fitting into the hormone’s molecular surface.
superimposed on the surface of IFN-gRa(INSIGHTII [52]). Receptor This receptor loop contributes about 200 A˚2 to the buried
residues making up the principal binding interface are colored green surface area. This loop is found to exist in a conformation
and labeled by arrows.
placing Val206 well into a “disallowed” region in the
Ramachandran plot (` 5 738, c 5 2738) [22]. However,
the electron density from a simulated annealing omitreceptor [20], 908; IL-4 receptor [21], 908). The IFN-gRa
map clearly indicates that the model of the tripeptide ismolecule also contains two helical turns: a1 (residues
fit correctly (Figure 4). The conformation adopted by71–73) in the loop connecting strands E and F in the
Val206, while rare, has been described previously as aN-terminal domain and a2 (residues 104–107) in the in-
classic g turn [23, 24]. Such turns are characterized byterdomain linker (Figure 1).
an i to i 1 2 hydrogen bond, and are typically found (as
is the case here) at the end of b hairpin structures [25].The Hormone-Receptor Binding Interface
Thus, it appears that the energy cost of the loop adopt-Upon complex formation, an average of 940 A˚2 of surface
becomes buried on each molecule. Figure 2 displays
the surface area buried for each molecule on a residue-
by-residue basis and shows the distribution of binding Table 1. Intermolecular H-Bonds and Salt Bridges
determinants between the two repeats of the hormone.
Hormone Atom Receptor Atom Distancea (A˚)
The relatively large amount of burial observed for Ser20
GLN1 Ne2 TRP207 O 2.8/3.1and Ala23 is based on the contribution of their main
LYS12 Nz GLU101 Oe1 3.2/(3.5)chain atoms to the interface.
LYS12 Nz GLU101 Oe2 2.7/2.8
For scIFN-g, the receptor binding surface consists of GLY18 O TRP82 Ne1 3.0/2.8
residues from both monomeric repeats. The first seg- ASP24 Od1 LYS47 Nz 2.7/2.7
ment includes parts of helix A, helix B, and the loop ASN25 N ALA53 O 2.8/2.8
ASN25 N VAL51 O 3.2/(3.9)connecting them (residues 1–34) from the first chain; the
GLY26 N VAL51 O 2.6/2.6second contains helix F’ and the C terminus (residues
GLU312 Oe2 TYR49 Oh 2.7/2.6108’–124’) of the second chain. Receptor residues in-
GLN315 Ne2 ASN79 Od1 (3.3)/3.1
volved in the interface come from a more disperse epi- GLN315 Ne2 SER78 O (3.4)/3.1
tope: strands C, F, and G, as well as the CC’ and EF
a Distances are given for each complex in the crystallographic asym-loops of the first FNIII domain (D1); a portion of the
metric unit, and distances .3.2 A˚ are in parentheses.
interdomain linker, including the short helix (a2); and
Structure
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Table 2. Bridging Water Molecules
Hormone Atom Distancea (A˚) Water Distancea (A˚) Receptor Atom
HIS1119 Ne2 2.94/3.01 WAT 12 2.87/2.90 SER80 N
GLN1159 Oe1 3.06/3.22 WAT 12 2.87/2.90 SER80 N
ASP2 N 3.03/3.39 WAT 33 2.84/2.54 VAL206 O
SER20 Og 2.84/2.69 WAT 35 2.77/2.89 LYS47 Nz
ASP21 Od1 2.73/2.86 WAT 35 2.77/2.89 LYS47 Nz
GLN1159 Ne2 2.90/3.10 WAT 60 2.60/2.81 THR149 Og1
GLY18 O 3.11/3.09 WAT 61 3.04/3.05 GLU101 N
a Distances are given for each complex in the crystallographic asymmetric unit. Prime numbers are residues in second monomer.
ing the g turn conformation is offset by the efficiency molecules, as well as the nature and size of the interface,
appear similar to the 2.0 A˚ resolution structure pre-with which this conformation can provide the full effect
of the side chains of this tripeptide to the binding in- sented here. There are, however, several pertinent differ-
ences between the two models that have implicationsterface.
There is no interpretable electron density for the six to the interpretation of the roles of certain residues in
the hormone-receptor interface. Additionally, the higherC-terminal residues of the scIFN-g construct. The unre-
solved scIFN-g C terminus contains the basic sequence resolution structure allows assignment of important
structured water molecules in the interface as well asLys-Arg-Lys-Arg (residues 128’–131’), a region critical
for receptor binding and antiviral activity [14]. The last some unusual stereochemistries that maximize protein–
protein contacts.ordered residue of the C terminus points toward a face
of the receptor that contains the BC and C’E loops of Walter et al. report that all nonglycine residues have
main chain dihedral angles in allowed regions of `-cthe second FNIII domain, which themselves are only
partially ordered. The BC loop contains the acidic se- space [9]. As discussed above, residue Val206 of the
receptor in the 1:1 complex adopts a conformation typi-quence Asp-Glu-Gln-Glu-Val-Asp-Tyr-Asp (residues 138–
145). The C’E loop contains the acidic cluster Glu-Asp-
Asp-Cys-Asp-Glu (residues 175–180). These acidic loops
form a logical binding site for the basic C terminus of
scIFN-g (Figure 1). If such an interaction exists, the lack
of interpretable electron density in this region indicates
that it is disordered in the time-averaged structure.
Intermolecular H-Bonding Interactions
There are eight hydrogen bonds and two salt bridges
(, 3.2 A˚) in the hormone-receptor interface (Table 1).
Three of these H-bonds are main chain–main chain,
three are side chain–main chain, and two are side chain–
side chain. Examination of the hormone-receptor inter-
face indicates water molecules play a significant role in
the binding properties of the interface. There are five
water molecules that bridge the donor-acceptor groups
of the hormone and receptor through H-bonding (Table
2). Additionally, there are five water molecules that par-
ticipate in networks involving two waters that span the
interface. Figure 5a shows an example of both classes
of water molecules. This contact epitope is important
because the His111’Asp mutation on IFN-g significantly
impairs receptor binding [26] (see below). Nevertheless,
His111’ makes no direct contact with the receptor; the
interaction is mediated by a structured water molecule.
The average temperature factor of the water molecules
(35 A˚2) in the interface is the same as the average for
the protein (37 A˚2). At this level of ordering, these waters
can be considered an integral part of the interface.
Figure 5. Close Up of the Hormone:Receptor Interface
(Top) Stereo view of the bridging water network in the region ofComparison with the 1:2 IFN-g:IFNg-Ra Structure
H111’. The Ne2 of H111’ H-bonds to water (Wat 12), while its Nd1The 2.9 A˚ resolution X-ray structure of IFN-g bound to
H-bonds to the carbonyl oxygen of A17. (Bottom) A 2Fo-Fc maptwo copies of IFN-gRa ECD has been previously re-
contoured at 1s showing the electron density of Wat 12. Although
ported [9]. This complex indicated that the two receptors the side chain of E101 of the receptor is in close proximity, the
do not interact with each other and are separated by a orientation of the imidazole ring unequivocally indicates the H-bond-
ing partners. Figure generated using MIDASPLUS [51].minimum distance of 27 A˚. In general, the individual
A 1:1 IFN-g:IFN-gRa Complex at 2.0 A˚
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Figure 6. Structural Comparison of IFN-g
and hGH Binding
Comparison of the binding interfaces be-
tween IFN-g:IFN-gRa (left) and hGH:hGHR at
Site 1 (right). The molecules have been ro-
tated to expose their binding surfaces, and
the residues buried upon complex formation
are marked in red. Loops of the receptors are
named based on the b strands they connect.
Figure generated using MIDASPLUS [51].
cally referred to as disallowed [21]. Given the similarity vates the hormone, involves a specific charge repulsion
feature. Based on this structure, the repulsion could beof the two complexes and the fact that this residue
is located in the hormone-receptor interface, it seems directly influenced by the relatively close proximity of
the Asp to Glu101.unlikely that the conformation of this amino acid differs
between the two structures. Instead, the lower resolu-
tion of the 1:2 structure probably masked a clear inter- Discussion
pretation, leading Walter et al. to model this residue in
an incorrect, albeit low-energy, conformation. Comparison to the Human Growth Hormone
1:2 Hormone: Receptor StructureA second difference between the two structures is
in three charged interactions in the hormone-receptor The structure of 1:2 hGH:hGHR (hGH: hGHR2) complex
provided the first example of a complex between theinterface. In the scIFN-g:IFN-gRa complex, there is a
well-defined salt bridge (2.7 A˚) formed between Lys12Nz ECD of a member of the Class 1 hematopoeitic receptor
superfamily and its cognate ligand [17]. Subsequently,of the hormone and Glu101Oe2 of the receptor not
found in the 1:2 complex. Conversely, two salt bridges several other class 1 receptor complex structures have
been reported [18–21]. The scIFNg:IFN-gRa complex isreported in the 1:2 complex but absent from the
scIFN-g:IFN-gRa are Glu9Oe1/Arg109Nh2 (2.9 A˚) and composed of molecules from Class 2 of this superfamily.
Comparisons of these related complexes identify fea-His111’Ne2/Glu101Oe1 (2.9 A˚) (see below).
Figure 5b shows the electron density in the region of tures that are both common and distinct between these
two classes.His111’ and illustrates the importance of high-resolution
data in structural interpretation. In the assigned confor- The structural topology is similar for both IFN-gRa
and hGHR. One notable difference between them is themation, the imidazole side chain H-bonds to the car-
bonyl oxygen of Ala17 (2.9 A˚) of the hormone and orientation between their two FNIII domains. Following
superposition of the C-terminal domains, an z308 rota-through its Ne2 to a water (2.9 A˚) that is an integral part
of a four-water network bridging the hormone-receptor tion is required to align the N-terminal domains. As a
result of the more linear arrangement for the two do-interface (Figure 5a). Besides H-bonding to His111’, this
water coordinates the Ne2 of Gln1159 of the hormone mains in IFN-gRa, the loop connecting b strands A and
B, part of the ligand binding epitope for the hGHR, isand the peptide amide of Ser80 of the receptor. Although
Glu101 of the receptor is close to the imidazole ring buried in the domain–domain interface of IFN-gRa (Fig-
ure 6).of His111’ (3.2 A˚), the stereochemistry of the above
H-bonding scheme unequivocally defines the conforma- Despite the difference in orientation, the two recep-
tors still use residues from many of the same structuraltion of the ring in a position where they cannot H-bond.
Note that changing His111’ to one of several side chain elements to bind their respective hormones. While both
receptors use a section of their C-terminal domains fortypes has little apparent effect on binding [26], sug-
gesting that the specific mutation to Asp, which inacti- hormone binding, it is the N-terminal domains that con-
Table 3. Antiviral Activities of IFN-g Variants
No. Binding
Varianta Sites Mutated Activity (U/mg) Relative Activity
wt 0 3.1 3 104 100
H111D 2 ,2.5 3 1022 ,0.00008
V5E/S20E/A23F/G26Q 2 ,2.5 3 1022 ,0.00008
sc 1 2.6 3 102 0.8
sc/H111D 1 7.0 3 101 0.1
sc/H1119D 2 ,2.5 3 1022 ,0.00008
sc/V59E/S209E/A239F/G269Q/H111D 1 3.3 3 102 1.0
a Sc refers to the single-chain variant described in the text.
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tribute the majority of residues to the hormone-receptor
interface. Figure 6 compares the size and organization
of the hormone-receptor epitopes for the IFN-g and hGH
systems. Similarly, the two hormones also use residues
from equivalent structural elements to bind their respec-
tive receptors. These include helix A, the AB loop, and
the C-terminal helix. However, these two interfaces con-
tact their receptors in quite different orientations. It re-
quires a rotation of z508 to align the more vertical helices
of the IFN-g molecule with those of the hGH molecule.
In their respective complexes, the binding of hGH to
its receptor is significantly tighter than that for IFN-
g:IFN-gRa binding. On the cell surface, the tight binding
of IFN-g is developed by avidity via the hormone’s biva-
lent character; the individual sites on the symmetric ho-
modimer combine to give a very strong product. In con-
trast, the binding affinity of hGH is developed through
two asymmetric binding sites (referred to as site 1 and
site 2) that have different binding affinities and become
Figure 7. Signaling Mechanism
occupied in a sequential order.
Proposed signaling mechanism of wt IFN-g (left) and scIFN-g (right).
The hGH site 1 interface buries z1300 A˚2 of surface Stat1 binds to phosphorylated Tyr440 on IFN-gRa. It is phosphory-
area, while the IFN-g:IFN-gRa complex buries about lated itself and dimerizes and translocates to the nucleus. In the
two-thirds of that (z940 A˚2). The energy contribution 1:2:2 complex (left) the Stat1 dimer can be formed between mole-
cules from the same complex. In the 1:1:1 complex the dimer needsand distribution of the residues on the hormones that
to be recruited between two different complexes.are important for receptor binding also differ in character
between hGH and IFN-g. The binding of hGH to hGHR
is characterized by an energy “hot spot.” Of the 30 resi-
pattern of stacked charged and aromatic residues seendues of hGH that contact the receptor, 8 residues con-
in both the human growth hormone [17] and prolactintribute almost 85% of the total binding energy [27].
[18] receptors. While it has been speculated that theseThese residues are positioned in close spatial proximity.
residues present a surface that may be recognized byIn the case of IFN-g, Ala-scanning mutagenesis shows
an accessory protein [6], to date no biological functionthat the binding energy has a much broader spatial dis-
has been assigned to this motif.tribution (G. Pal, unpublished data).
While the binding energetics of residues in hGHR that
Biological Activity of Single-Chain IFN-ginterface hGH have been extensively characterized,
Available data suggest the IFN-g signaling complex con-there is very little similar mutagenesis data for IFN-gRa.
sists of one IFN-g homodimer, two IFN-gRa’s, and twoThe results of the hGHR binding analysis have shown
IFN-gRb’s [8]. The scIFN-g is an ideal molecule to assessthat hydrophobic interactions account for the majority
the validity of this proposed stoichiometry. It is pre-of binding energy. Mutation of either residue Trp104 or
sumed that the intermediate scIFN-g:IFN-gRa com-Trp169 to Ala results in a complete loss of hormone
plex can recruit and bind productively one copy of thebinding [27]. These two residues are spatially adjacent
IFN-gRb receptor, the third component of the activeto one another, binding in a groove on the surface of
complex.hGH. The erythropoietin (EPOR) receptor has a similar
The wild-type IFN-g and six variants were tested forhydrophobic “hot spot” [20]. Analysis of the IFN-g:IFN-
biological activity in a viral protection assay using A549gRa complex reveals that a portion of the interface has
cells derived from a human lung cell carcinoma [28].a disposition of aromatic residues similar to W104 and
Three of these molecules had the native two-chain con-W169 in the hGH:hGHR complex. Tyr49 and Trp82 of
struction; the other four were based on the single-chainIFN-gRa bind in a cleft between the AB loop and the
format. These molecules contain elements that eitherC-terminal helix of IFN-g. The similarity of these two sites
affected none, one, or both of the potential receptorwould suggest a major energetic binding contribution
binding sites. A description of these molecules and theirfrom Tyr49 and Trp82, but detailed mutational and bind-
biological activity is presented in Table 3. They indicateing experiments are needed to confirm this hypothesis.
that the point mutation His111Asp in both receptor bind-One of the features distinguishing class I from class
ing sites inactivates the hormone, as does a combinationII hematopoeitic receptor sequences is the presence of
of four mutations (Val5Glu, Ser20Glu, Ala23Phe, andthe so called “WSXWS” box near the beginning of b
Gly26Gln) in the two chain format. These fully inactivestrand G of the C-terminal FNIII domain [6]. Although
variants were reduced .106 in activity compared to thethe sequences of the two IFN-gRa domains differ from
wild-type IFN-g. However, it is noteworthy that thesethis consensus sequence (ESAYA in the N-terminal do-
data indicate that the single-chain molecules with onemain; TTEKS in the C-terminal domain), both domains
productive binding site retain about 1% of the wild-have a backbone conformation consistent with the ca-
type activity. While this represents a clear decrease innonical WSXWS conformation first described by Somers
activity, it indicates that the single-chain constructs thatet al. for prolactin receptor [18]. The structural conserva-
tion in the N-terminal domain extends to an alternating block only one site display almost four logs of activity
A 1:1 IFN-g:IFN-gRa Complex at 2.0 A˚
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Table 4. Data Collection and Refinement Statisticsa
Diffraction Data Statistics
Data Set Rotating Anode Synchrotron
Space group P21 P21
Cell constants a 5 72.8 A˚ b 5 107.8 A˚ c 5 85.2 A˚ b 5 98.08 a 5 73.1 A˚ b 5 107.8 A˚ c 5 85.1 A˚ b 5 97.98




Rsymb (%) 8.9(26.2) 5.3(20.9)
Refinement
Rcrystc (F . 0) (%) 19.4




Average B factors (A˚2)
Protein (6962 atoms) 36.0
Chloride (1 atom) 20.0
Solvent (481 atoms) 43.9
The asymmetric unit cell contained two copies of the complex, which were refined independently. Superposition of the two complete complexes
gives an rmsd of 0.52 A˚. This value is essentially identical to that obtained from comparison of the two hormones (0.50 A˚) and for the two
receptors (0.49 A˚) individually.
a Values in parentheses refer to the highest resolution bin.
b Rsym 5 ShkljIhkl 2 ,Ihkl.j/ShklIhkl, where Ihkl is the intensity of reflection hkl.
c Rcryst 5 ShkljjFobsj 2 jFcalcjj/jFobsj, where Fobs and Fcalc are the observed and calculated structure factors, respectively, for the data used in
refinement.
d Rfree 5 ShkljjFobsj 2 jFcalcjj/jFobsj, where Fobs and Fcalc are the observed and calculated structure factors, respectively, for 10% of the data omitted
from refinement.
over the baseline established by the inactive variants. portion. IFN-gRa associates with JAK1 [7, 35] and is
We note that recent studies using different forms of the required for ligand binding, ligand trafficking, and signal
IFN-g single chain dimer also show activity [12, 13]. transduction. IFN-gRb is essential for signaling through
The structural interpretation and implications of these its association with JAK2 [7, 36, 37]. Targeted phosphor-
results are discussed below. ylation of a key tyrosine residue within the sequence
YDPH at the C terminus of IFN-gRa [38, 39] provides a
docking site for the cytosolic transcription factor Stat1Biological Implications
[40]. The Stat1 molecules are themselves phosphory-
lated, followed by dimerization and translocation to theFigure 7a illustrates the JAK/STAT signaling pathway
nucleus, where they promote transcriptional activationused by IFN-g for receptor activation and signal trans-
of IFN-g inducible genes. It had been assumed that theduction [8, 29, 30]. The initiation event for signaling is
dimerized pair of Stat1 molecules was derived fromthe formation of a complex containing three compo-
within the same 1:2:2 complex.nents: the dimeric hormone and two different receptors
The observed level of activity of the scIFN-g variantof the Class 2 cytokine receptor superfamily, IFN-gRa
indicates that effective signaling can occur upon forma-and IFN-gRb. On stimulated cells, these components
tion of a 1:1:1 complex and that the required phosphory-come together to form an active complex with a 1:2:2
lation events can be achieved through single copies ofstoichiometry [31, 32]. In the complex, the receptors
the receptor-bound JAK1 and JAK2 tyrosine kinases.perform different functions that together provide the
Figure 7b illustrates the organization of the cytoplasmicjuxtapositioning of the key elements for recognition,
elements of the proposed complex. This 1:1:1 complexbinding, and phosphorylation.
is probably inherently transient, suggesting that to haveThe mechanism of complex association has been
a level of activity at z1%, the cross-phosphorylationthought to follow a sequential series of events based
steps between the cytoplasmic components are rela-on the bivalent character of the dimeric IFN-g. The first
tively efficient. A similar situation is observed in thestep involves the extracellular domain of IFN-gRa bind-
prolactin-receptor signaling pathway. In that system,ing to one binding site on the hormone. This initially
the binding of the second receptor to the intermediateforms a 1:1 association, which is followed by a second
1:1 hormone-receptor complex to form the active 1:2IFN-gRa binding event to form a tight 1:2 complex [33,
complex is also highly transient in nature [41, 42]. A34]. It had been thought that this 1:2 complex is required
noteworthy similarity is that both the prolactin receptorto form the stable scaffold for the binding of the two
and IFN-gRa and IFN-gRb have their requisite JAK ki-IFN-gRb receptors leading to the active 1:2:2 signaling
nases preassociated to the cytoplasmic portion of theircomplex (Figure 7a).
Both the receptors bind a JAK kinase on their cytosolic structures [7, 35, 37, 43]. In a number of related systems,
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